ubmslateEN-logo-ubm

EN Mobile Logo

Search form

Topics:

Insulin

Insulin 2016: Year-End News Roundup

In honor Frederick G. Banting’s birth 125 years ago, we present a review of developments in insulin for the year 2016.

 

© rook76/Shutterstock.com

 

 

Insulin

Our April list includes predictors of fracture risk, endocrine-disrupting chemicals, and CV effects of thyroid dysfunction.

A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.

Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.

Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.

A new set of guidelines will help people with type 1 diabetes mellitus exercise safely to avoid fluctuations in blood sugar.

The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.

March news includes a possible biomarker for diabetes, a new sensor to read glucose levels, and a study on insulin resistance and bone fracture.

Pages

Subscribe to Insulin on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.